Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Maintenance Apatinib After Second-Line Treatment for Locally Recurrent or Metastatic Nasopharyngeal Carcinoma

NCT03130270 is registered in ClinicalTrials.gov with Guilin Medical University, China as lead sponsor.

NCT NCT03130270
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03130270 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Maintenance Apatinib After Second-Line Treatment for Locally Recurrent or Metastatic Nasopharyngeal Carcinoma
Lead sponsor
Guilin Medical University, China
Phase
Phase 2
Overall status
Unknown status
Start date
January 1, 2017
Completion date
December 8, 2019
Enrollment
29 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

nasopharyngeal carcinoma